Skip to content
OpenCapital
Get started

Utah Medical Products UTMD EBITDA

EBITDA at other companies

TFX
TeleflexTFX
$73.93M-35.4%
IAR
Integra LifeSciencesIART
$53.68M+111%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$74.65M+6.2%
PDE
Pro-Dex, Inc.PDEX
$3.46M-12.5%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
——
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

$2.6Mebit+
$673.0KDepreciation Depletion & Amortization
=$3.24M

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's EBITDA?
Utah Medical Products (UTMD) reported EBITDA of $3.24M in Q1 2026.
How has Utah Medical Products's EBITDA changed year-over-year?
Utah Medical Products's EBITDA decreased by 16.2% year-over-year, from $3.86M to $3.24M.
What is the long-term trend for Utah Medical Products's EBITDA?
Over 4 years (2021 to 2025), Utah Medical Products's EBITDA has grown at a -13.9% compound annual growth rate (CAGR), from $26.16M to $14.35M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.